EE03422B1 - Kompositsioonid IRDS ja ARDS raviks - Google Patents

Kompositsioonid IRDS ja ARDS raviks

Info

Publication number
EE03422B1
EE03422B1 EE9700084A EE9700084A EE03422B1 EE 03422 B1 EE03422 B1 EE 03422B1 EE 9700084 A EE9700084 A EE 9700084A EE 9700084 A EE9700084 A EE 9700084A EE 03422 B1 EE03422 B1 EE 03422B1
Authority
EE
Estonia
Prior art keywords
compositions
treatment
irds
ards
glucocorticosteroid
Prior art date
Application number
EE9700084A
Other languages
English (en)
Estonian (et)
Other versions
EE9700084A (et
Inventor
Germann Paul-Georg
Eistetter Klaus
Kilian Ulrich
H�fner Dietrich
Original Assignee
Byk Gulden Lomberg Chemische Fabrik Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chemische Fabrik Gmbh filed Critical Byk Gulden Lomberg Chemische Fabrik Gmbh
Publication of EE9700084A publication Critical patent/EE9700084A/xx
Publication of EE03422B1 publication Critical patent/EE03422B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EE9700084A 1994-09-28 1995-09-27 Kompositsioonid IRDS ja ARDS raviks EE03422B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4434629A DE4434629C1 (de) 1994-09-28 1994-09-28 Zusammensetzungen zur Behandlung von IRDS und ARDS
PCT/EP1995/003816 WO1996009831A2 (de) 1994-09-28 1995-09-27 Zusammensetzungen zur behandlung von irds und ards, die mindestens ein glucocorticosteroid in kombination mit einem lungen surfactant enthalten

Publications (2)

Publication Number Publication Date
EE9700084A EE9700084A (et) 1997-10-15
EE03422B1 true EE03422B1 (et) 2001-06-15

Family

ID=6529394

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700084A EE03422B1 (et) 1994-09-28 1995-09-27 Kompositsioonid IRDS ja ARDS raviks

Country Status (26)

Country Link
US (1) US5891844A (da)
EP (1) EP0783314B1 (da)
JP (1) JP4425991B2 (da)
KR (1) KR100365030B1 (da)
CN (1) CN1100542C (da)
AT (1) ATE241372T1 (da)
AU (1) AU705099B2 (da)
BG (1) BG62556B1 (da)
CA (1) CA2201377C (da)
CZ (1) CZ292846B6 (da)
DE (2) DE4434629C1 (da)
DK (1) DK0783314T3 (da)
EE (1) EE03422B1 (da)
ES (1) ES2201120T3 (da)
FI (1) FI118886B (da)
HK (1) HK1003869A1 (da)
HU (1) HU226958B1 (da)
MX (1) MX9702303A (da)
NO (1) NO313405B1 (da)
NZ (1) NZ294587A (da)
PL (1) PL187496B1 (da)
PT (1) PT783314E (da)
RU (1) RU2157222C2 (da)
SK (1) SK284446B6 (da)
UA (1) UA43378C2 (da)
WO (1) WO1996009831A2 (da)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
PT977577E (pt) * 1997-02-17 2007-02-28 Altana Pharma Ag Composições para o tratamento de ards ou irds contendo 3-(ciclopropilmetoxi)-n- (3,5-dicloro-4-piridinil)-4-(difluorometoxi) benzamina e tensioactivo pulmonar.
US7122344B2 (en) 1997-05-28 2006-10-17 Claragen, Inc. Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
US20060281681A1 (en) 1997-05-28 2006-12-14 Pilon Aprile L Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6946117B1 (en) * 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20020017295A1 (en) * 2000-07-07 2002-02-14 Weers Jeffry G. Phospholipid-based powders for inhalation
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
CN1194833A (zh) * 1997-10-08 1998-10-07 刘柏宏 肺活素
US6858223B2 (en) 1998-06-23 2005-02-22 Altana Pharma Ag Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ARDS) and infant respiratory distress syndrome (IRDS)
WO2000076535A1 (en) * 1999-06-11 2000-12-21 Byk Gulden Lomberg Chemische Fabrik Gmbh Pharmaceutical preparation containing modifications of surfactant protein b (sp-b) and surfactant protein c (sp-c)
AU6083899A (en) * 1999-09-16 2001-04-17 Aventis Behring Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
DE19957898A1 (de) * 1999-12-01 2001-06-07 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant
JP2003530356A (ja) * 2000-04-12 2003-10-14 アルタナ ファルマ アクチエンゲゼルシャフト 急性肺疾患の予防又は早期治療のための肺表面活性物質の新規使用
DE10018022A1 (de) * 2000-04-12 2001-10-31 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant zur Prophylaxe oder Frühbehandlung von akuten Lungenerkrankungen
US20040254112A1 (en) * 2000-04-12 2004-12-16 Dietrich Hafner Use of pulmonary surfactant for the early treatment of acute pulmonary diseases
US7442388B2 (en) * 2000-05-10 2008-10-28 Weers Jeffry G Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
DE10132307A1 (de) * 2001-07-06 2003-01-30 Aventis Behring Gmbh Arzneizubereitung zur Inhalation von Antithrombin bei entzündlichen Lungenerkrankungen und ARDS
US20030099601A1 (en) * 2001-11-27 2003-05-29 Gordon Marc S. Inhalation lung surfactant therapy
AU2002357168A1 (en) * 2001-12-12 2003-07-09 Penn State Research Foundation Surfactant prevention of lung complications from cancer chemotherapy
SI1458360T1 (sl) 2001-12-19 2011-08-31 Novartis Ag Pulmonalno dajanje aminoglikozidov
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
JP2006527737A (ja) 2003-06-16 2006-12-07 アルタナ　ファルマ　アクチエンゲゼルシャフト 肺サーファクタントとｐｄｅ５阻害剤とを含有する肺疾病の治療用の組成物
EP1670482B2 (en) * 2003-09-16 2022-06-29 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases
US7582312B2 (en) 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
SI1841458T1 (sl) 2005-01-06 2012-04-30 Discovery Lab Inc Zdravljenje s predpisanim odmerjanjem surfaktanta za zdravljenje ali preprečevanje bronhopulmonalne displazije
KR100891595B1 (ko) 2005-02-28 2009-04-03 주식회사 케이티앤지 혈액 단백질의 삼출을 감소시키는 조성물
KR20090060348A (ko) * 2006-09-19 2009-06-11 디스커버리 래보래토리스, 인크. 폐 계면활성제 제제 및 점액 클리어런스 촉진 방법
EP2022798A1 (en) * 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides
WO2012077127A1 (en) * 2010-12-10 2012-06-14 Indian Institute Of Technology, Bombay A protein free surfactant composition for pulmonary diseases and a process for preparing the same
WO2013188016A2 (en) 2012-05-04 2013-12-19 Discovery Laboratories, Inc. Surfactant therapy for exposure to ionizing radiation
CN106310280A (zh) * 2016-08-18 2017-01-11 滨州医学院 地瑞那韦增强糖皮质激素抗炎作用的医药新用途
PL3558376T3 (pl) * 2016-12-22 2022-02-14 Chiesi Farmaceutici S.P.A. Kombinacja terapeutyczna zawierająca surfaktant płucny i steroid do leczenia rozwijającej się BPD

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4944941A (en) * 1987-08-07 1990-07-31 Genentech, Inc. Methods and compositions for the treatment of lung conditions
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances

Also Published As

Publication number Publication date
US5891844A (en) 1999-04-06
DE4434629C1 (de) 1996-06-27
HUT77931A (hu) 1998-11-30
NZ294587A (en) 1998-07-28
PL319608A1 (en) 1997-08-18
SK284446B6 (sk) 2005-04-01
KR100365030B1 (ko) 2003-03-10
FI118886B (fi) 2008-04-30
JPH10506119A (ja) 1998-06-16
UA43378C2 (uk) 2001-12-17
WO1996009831A3 (de) 1996-05-23
KR970706006A (ko) 1997-11-03
EP0783314A2 (de) 1997-07-16
FI971277A0 (fi) 1997-03-26
EE9700084A (et) 1997-10-15
AU3742895A (en) 1996-04-19
AU705099B2 (en) 1999-05-13
DE59510705D1 (de) 2003-07-03
PT783314E (pt) 2003-10-31
BG101441A (en) 1997-09-30
NO971403D0 (no) 1997-03-25
JP4425991B2 (ja) 2010-03-03
CA2201377C (en) 2008-07-29
HU226958B1 (en) 2010-03-29
NO313405B1 (no) 2002-09-30
HK1003869A1 (en) 1998-11-13
CZ94097A3 (en) 1997-09-17
NO971403L (no) 1997-04-17
PL187496B1 (pl) 2004-07-30
WO1996009831A2 (de) 1996-04-04
BG62556B1 (bg) 2000-02-29
MX9702303A (es) 1997-06-28
FI971277A (fi) 1997-05-27
CN1100542C (zh) 2003-02-05
CA2201377A1 (en) 1996-04-04
CZ292846B6 (cs) 2003-12-17
EP0783314B1 (de) 2003-05-28
CN1163571A (zh) 1997-10-29
ES2201120T3 (es) 2004-03-16
RU2157222C2 (ru) 2000-10-10
SK40197A3 (en) 1998-02-04
DK0783314T3 (da) 2003-12-01
ATE241372T1 (de) 2003-06-15

Similar Documents

Publication Publication Date Title
EE03422B1 (et) Kompositsioonid IRDS ja ARDS raviks
DE68922314D1 (de) Synergetische brennstoffzusammensetzung.
FI910393A0 (fi) Semi-termoplastisk matriskomposition med vaermestabilt formbestaendigt minne.
EP0313305A3 (en) Photoprotection compositions comprising chelating agents
FI893127A0 (fi) Komposition som bildar en vattenavstoetande film.
DE69105462D1 (de) Desinfizierende Zusammensetzung.
DE68920444D1 (de) Kurzfasern und elastomere, verstärkte zusammensetzung mit kurzfasern.
DE69107162D1 (de) Elektronenquelle mit teilchenhaltender Anordnung.
FI893206A (fi) Transportanordning.
DE69001295D1 (de) In zufuhranlage niederschlaege kontrollierende zusammensetzungen.
ES1025426Y (es) Frigorifico con entrepaño perfeccionado.
DE3854179D1 (de) Vulkanisierbare Fluorkautschukzusammensetzung.
DE3869806D1 (de) Zusammensetzung gegen leberkrankheiten.
ATE197812T1 (de) Safranspirituose
ATE289819T1 (de) Gedächnissverbesserung durch verabreichung von delta-5-androsten-3-beta-ol-7,17-dion und 3-beta- estern desselben
DE3863687D1 (de) Tinten-zusammensetzungen und deren zubereitung.
FI923812A0 (fi) Anordning foer aostadkommande av en rymdladdning i atmosfaeren.
FI914156A0 (fi) Kompositioner.
DE69112642D1 (de) Glutaminhaltige lyophilisierte aminokarbonsäurenzusammensetzungen.
IT8822296A0 (it) Composizione di combustibile ad elevato contenuto energetico.
DE3872764D1 (de) Tinten-zusammensetzungen und deren zubereitung.
DE59008045D1 (de) Zusammensetzungen mit Dichlormonofluorethanen.
DE69019395D1 (de) Zusammensetzung gegen Mikroben.
ITMI940685V0 (it) Tratto di trasporto con almeno due trasportatori estendentisi trasversalmente l'uno rispetto all'altro
DK346387D0 (da) Fremgangsmaade til at reducere alkaliindholdet i cementklinker

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231